Wells Fargo Maintains Overweight on iRhythm Holdings, Lowers Price Target to $168
Wells Fargo analyst Nathan Treybeck maintains iRhythm Holdings (NASDAQ:IRTC) with a Overweight and lowers the price target from $180 to $168.
Stocks · News reference
iRhythm Technologies Q2 Adj. EPS $0.58 Beats $(0.00) Estimate, Sales $224.172M Beat $219.324M Estimate
iRhythm Technologies (NASDAQ:IRTC) reported quarterly earnings of $0.58 per share which beat the analyst consensus estimate of $(0.00) by Infinity percent. This is a 281.25 percent increase over losses of $(0.32) per
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — iRhythm Holdings, Inc. (IRTC)
Filed: 2026-08-13 AccNo: 0001388658-26-000076 Size: 140 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Truist Securities Maintains Buy on iRhythm Holdings, Raises Price Target to $168
Truist Securities analyst Richard Newitter maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and raises the price target from $160 to $168.
iRhythm Combines Strong Performance with VitalConnect Buy to Expand Remote Cardiac Care
iRhythm to acquire VitalConnect for $287.5 million, expands cardiac monitoring portfolio after Q2 earnings beat and higher fiscal 2026 guidance.